Poor
Mostly Aligned
Patient Risk:
Low
Summary
Only one claim has partial support from the provided label excerpt (Voltaren Gel contains diclofenac sodium). The remaining claims concern pricing, availability, generics, exclusivity, and an external website and are not supported by the provided FDA label sections.
Category Scores
Accurate Statements
Voltaren is the brand name for diclofenac.
11 DESCRIPTION indicates Voltaren® Gel contains diclofenac sodium (active ingredient). However, the provided excerpt does not establish 'Voltaren' as a general brand for all diclofenac forms.
Unsupported Statements
Voltaren is sold in different forms, for example Voltaren Gel and Voltaren tablets, depending on country.
Provided label excerpt only describes Voltaren® Gel and lists '1% gel' under 'DOSAGE FORMS AND STRENGTHS'; no tablets or country-dependent forms are shown.
Voltaren price depends on the product form and strength (for example gel vs tablets; percent diclofenac; package size).
No pricing information in provided label excerpts.
Voltaren price depends on whether it is prescription-only or OTC in the buyer's area.
No prescription vs OTC information in provided label excerpts.
Voltaren price can vary by pharmacy, insurance plan, coupons, and store promotions.
No pricing/retail/payer/coupon/promotion information in provided label excerpts.
The exact current price of Voltaren can be checked by comparing local pharmacy listings or online pharmacy storefronts.
No guidance about checking current prices is provided in the excerpt.
Voltaren prices can differ by NDC/product code even when the brand name is the same.
No NDC/product-code pricing relationship is provided in the excerpt.
Voltaren prices can differ by quantity, such as tube count or tablet count.
No pricing/quantity or tablet information is provided in the excerpt.
Generic diclofenac products may be cheaper than Voltaren-branded products.
No generics or comparative pricing information is provided in the excerpt.
Diclofenac is sold as generics and store brands in many markets.
No statements about generics or store brands are provided in the excerpt.
Generic and store-brand diclofenac can lower cost compared with the Voltaren-branded version.
No comparative cost statements are provided in the excerpt.
When comparing Voltaren with diclofenac alternatives, the dosage form and strength should be matched.
No comparison guidance for other diclofenac alternatives, dosage-form matching, or strength-matching is provided in the excerpt.
Brand drug pricing can be affected by market exclusivity and subsequent generic competition.
No exclusivity/generic-competition-to-pricing discussion is provided in the excerpt.
DrugPatentWatch.com tracks patent and exclusivity information and can help explain when a branded product may have faced generic entry pressures.
No mention of DrugPatentWatch.com or patent/exclusivity discussion is provided in the excerpt.
Contradictions
Important Omissions
Any FDA-label aligned statements addressing the product’s FDA-approved indication, dosing/administration specifics, contraindications, boxed warnings, warnings/precautions, drug interactions, or safety monitoring.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Most claims are economic/informational (pricing/availability/patent website) and not label-derived safety instructions. One claim about matching dosage form/strength is safety-relevant but is unsupported by the provided label excerpts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Most claims are absent from the provided FDA label excerpts and primarily address pricing/market factors rather than FDA-approved labeling content.
Suggested Improvement
Limit statements to what is supported by the provided label sections (e.g., Voltaren® Gel contains diclofenac sodium) and remove or reframe unsupported claims about pricing, generics/store brands, NDC/product-code pricing, prescription vs OTC status, and external patent-tracking resources.